Digitalis Ventures backs early‑stage companies that address unmet needs in human and animal health, focusing on biotechnology, health‑technology platforms, and services that improve outcomes and reduce costs. Leveraging deep scientific, technical, and domain expertise, the firm partners with founders to finance, build, and scale enduring enterprises across the health spectrum.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
67.3%United Kingdom
12.2%Australia
4.1%Venezuela
4.1%Switzerland
2.0%Other
2.0%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Pre-Seed → Series A
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund IV
Vintage 2022 • $300M
Companion Fund II
Vintage 2023 • $300M